Dehydroepiandrosterone 13 mg/Gm Vaginal Gel

Dehydroepiandrosterone Vaginal Gel is a hormone therapy treatment used to help improve female sexual health and libido. It works by providing hormones to help increase desire and satisfaction during sexual activity for women suffering from Female Sexual Dysfunction. It is taken in a 13 mg/gm gel form and applied intravaginally.
Controlled substances must be E-Prescribed. Visit your Tutorials tab to learn how to prescribe.

Formula Information

Dehydroepiandrosterone 13 mg/Gm Vaginal Gel is a compounded medication used for the treatment of female sexual dysfunction and low libido in adult women. This medication contains a concentrated form of the hormone DHEA, which has demonstrated efficacy in studies for improving women’s sexual desire and arousal. The gel is formulated for the vaginal route of administration to allow the DHEA to be absorbed directly into the blood stream through the vaginal mucosa, providing an effective and consistent therapeutic dose of this hormone. The use of this formulation has been reported to increase sexual arousal, reduce pain and discomfort during intercourse, and improve overall satisfaction. If you have any questions regarding the use of this medication or its effects, do not hesitate to reach out to us.

Drug Interactions

Dehydroepiandrosterone Vaginal Gel is a hormone therapy treatment used to help improve female sexual health and libido. It works by providing hormones to help increase desire and satisfaction during sexual activity for women suffering from Female Sexual Dysfunction. It is taken in a 13 mg/gm gel form and applied intravaginally.

How Does it Work

Dehydroepiandrosterone (DHEA) is a naturally occurring hormone that is produced by the body’s adrenal glands. It plays an important role in regulating sex hormones, such as testosterone and estrogen. When used as a topical vaginal gel, it can have a beneficial effect on female sexual dysfunction (FSD). The gel, which typically comes in concentrations of 13 mg/gm, is applied topically to the inside of the vaginal wall. It is thought to work by modulating the local estrogen levels which can result in improved blood flow to the genitals, increased sensitivity to sexual stimulation, and improved vaginal lubrication. The gel is generally well tolerated and has few reported side effects. Most common side effects include minor itching, burning, and irritation in the area of application. Long term use of DHEA gel has been linked to increased risk of hormone-related cancers, such as breast and ovarian cancer, so it is important to discuss the potential risks and benefits of using DHEA gel with your doctor before beginning treatment. The effects of DHEA gel treatment can vary depending on the individual and the underlying cause of the FSD. Studies have found that the gel is most effective at improving symptoms of FSD in menopausal women who have lower than normal levels of estrogen. In addition, the gel may be beneficial for young women with FSD who have not responded to other treatments, such as cognitive behavioral therapy. Overall, DHEA gel is a promising option for treating FSD and it has the potential to improve the sexual health and quality of life of women who suffer from this condition.

Other Uses

Dehydroepiandrosterone 13 mg/Gm Vaginal Gel can be considered as a viable treatment option for a variety of gynecological issues due to its long-term efficacy and safety profile. In addition to treating Female Sexual Dysfunction/Libido, Dehydroepiandrosterone 13 mg/Gm Vaginal Gel may be useful in particular for treating postmenopausal atrophic vaginitis, genital atrophy and other types of vulvovaginal atrophy which are caused by the lack of endogenous estrogen production and can result in dryness, itching, and burning. Furthermore, this compound formulation may be of use for treating lichen sclerosus, which is a chronic inflammatory skin disorder with a high prevalence in postmenopausal women and has been associated with increased risk of developing vulvar cancer if left untreated. Lastly, Dehydroepiandrosterone 13 mg/Gm Vaginal Gel may also be recommended for treating genitourinary syndrome of menopause, a condition which can cause symptoms such as recurrent urinary tract infections, irritative and overactive bladder, and dyspareunia.
Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

Dehydroepiandrosterone 13 mg/Gm Vaginal Gel

Dehydroepiandrosterone Vaginal Gel is a hormone therapy treatment used to help improve female sexual health and libido. It works by providing hormones to help increase desire and satisfaction during sexual activity for women suffering from Female Sexual Dysfunction. It is taken in a 13 mg/gm gel form and applied intravaginally.

Formula Information

Dehydroepiandrosterone 13 mg/Gm Vaginal Gel is a compounded medication used for the treatment of female sexual dysfunction and low libido in adult women. This medication contains a concentrated form of the hormone DHEA, which has demonstrated efficacy in studies for improving women’s sexual desire and arousal. The gel is formulated for the vaginal route of administration to allow the DHEA to be absorbed directly into the blood stream through the vaginal mucosa, providing an effective and consistent therapeutic dose of this hormone. The use of this formulation has been reported to increase sexual arousal, reduce pain and discomfort during intercourse, and improve overall satisfaction. If you have any questions regarding the use of this medication or its effects, do not hesitate to reach out to us.

Drug Interactions

Dehydroepiandrosterone Vaginal Gel is a hormone therapy treatment used to help improve female sexual health and libido. It works by providing hormones to help increase desire and satisfaction during sexual activity for women suffering from Female Sexual Dysfunction. It is taken in a 13 mg/gm gel form and applied intravaginally.

How Does it Work

Dehydroepiandrosterone (DHEA) is a naturally occurring hormone that is produced by the body’s adrenal glands. It plays an important role in regulating sex hormones, such as testosterone and estrogen. When used as a topical vaginal gel, it can have a beneficial effect on female sexual dysfunction (FSD). The gel, which typically comes in concentrations of 13 mg/gm, is applied topically to the inside of the vaginal wall. It is thought to work by modulating the local estrogen levels which can result in improved blood flow to the genitals, increased sensitivity to sexual stimulation, and improved vaginal lubrication. The gel is generally well tolerated and has few reported side effects. Most common side effects include minor itching, burning, and irritation in the area of application. Long term use of DHEA gel has been linked to increased risk of hormone-related cancers, such as breast and ovarian cancer, so it is important to discuss the potential risks and benefits of using DHEA gel with your doctor before beginning treatment. The effects of DHEA gel treatment can vary depending on the individual and the underlying cause of the FSD. Studies have found that the gel is most effective at improving symptoms of FSD in menopausal women who have lower than normal levels of estrogen. In addition, the gel may be beneficial for young women with FSD who have not responded to other treatments, such as cognitive behavioral therapy. Overall, DHEA gel is a promising option for treating FSD and it has the potential to improve the sexual health and quality of life of women who suffer from this condition.

Other Uses

Dehydroepiandrosterone 13 mg/Gm Vaginal Gel can be considered as a viable treatment option for a variety of gynecological issues due to its long-term efficacy and safety profile. In addition to treating Female Sexual Dysfunction/Libido, Dehydroepiandrosterone 13 mg/Gm Vaginal Gel may be useful in particular for treating postmenopausal atrophic vaginitis, genital atrophy and other types of vulvovaginal atrophy which are caused by the lack of endogenous estrogen production and can result in dryness, itching, and burning. Furthermore, this compound formulation may be of use for treating lichen sclerosus, which is a chronic inflammatory skin disorder with a high prevalence in postmenopausal women and has been associated with increased risk of developing vulvar cancer if left untreated. Lastly, Dehydroepiandrosterone 13 mg/Gm Vaginal Gel may also be recommended for treating genitourinary syndrome of menopause, a condition which can cause symptoms such as recurrent urinary tract infections, irritative and overactive bladder, and dyspareunia.
Want this compounded medication? Click the Text Us button.